These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 35222288

  • 1. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
    Puglisi S, Leporati M, Amante E, Parisi A, Pia AR, Berchialla P, Terzolo M, Vincenti M, Reimondo G.
    Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ, Methlie P, Kellmann R, Bjørgaas M, Åsvold BO, Thorstensen K, Kelp O, Thordarson HB, Mellgren G, Løvås K, Husebye ES.
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [Abstract] [Full Text] [Related]

  • 3. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M, Hanzu FA, Pascual-Corrales E, García Cano AM, Marchan M, Escobar-Morreale HF, Valderrabano P, Casals G.
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [Abstract] [Full Text] [Related]

  • 4. Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome.
    Brossaud J, Charret L, De Angeli D, Haissaguerre M, Ferriere A, Puerto M, Gatta-Cherifi B, Corcuff JB, Tabarin A.
    Eur J Endocrinol; 2021 Mar; 184(3):445-454. PubMed ID: 33449913
    [Abstract] [Full Text] [Related]

  • 5. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F, Barbot M, Albiger N, Antonelli G, Zilio M, Todeschini M, Regazzo D, Plebani M, Lacognata C, Iacobone M, Mantero F, Boscaro M, Scaroni C.
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [Abstract] [Full Text] [Related]

  • 6. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
    Debono M, Harrison RF, Chadarevian R, Gueroult C, Abitbol JL, Newell-Price J.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3461-3469. PubMed ID: 28911138
    [Abstract] [Full Text] [Related]

  • 7. The Utility of Salivary Cortisone in the Overnight Dexamethasone Suppression Test in Adrenal Incidentalomas.
    Issa BG, Hanna FWF, Fryer AA, Ensah G, Ebere I, Marshall D, Keevil B.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):e937-e943. PubMed ID: 37155577
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
    Berndt V, Dahlqvist P, de Verdier J, Ryberg H, Ragnarsson O.
    Front Endocrinol (Lausanne); 2022 Sep 18; 13():1028804. PubMed ID: 36506050
    [Abstract] [Full Text] [Related]

  • 9. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S, Morelli V, Polledri E, Fustinoni S, Mercadante R, Olgiati L, Eller Vainicher C, Cairoli E, Zhukouskaya VV, Beck-Peccoz P, Chiodini I.
    Eur J Endocrinol; 2013 Mar 18; 168(3):289-96. PubMed ID: 23211572
    [Abstract] [Full Text] [Related]

  • 10. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
    Morelli V, Polledri E, Mercadante R, Zhukouskaya V, Palmieri S, Beck-Peccoz P, Spada A, Fustinoni S, Chiodini I.
    Endocrine; 2016 Sep 18; 53(3):809-15. PubMed ID: 26438395
    [Abstract] [Full Text] [Related]

  • 11. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul 18; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 12. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P, Mosconi C, Balacchi C, Golfieri R, Cosentino ER, Borghi C, Vicennati V, Pasquali R, Pagotto U.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5519-5528. PubMed ID: 31381072
    [Abstract] [Full Text] [Related]

  • 13. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T.
    Front Endocrinol (Lausanne); 2023 Nov 01; 14():1123132. PubMed ID: 37223045
    [Abstract] [Full Text] [Related]

  • 14. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE.
    J Endocrinol Invest; 2019 Dec 01; 42(12):1435-1442. PubMed ID: 31456173
    [Abstract] [Full Text] [Related]

  • 15. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N, Kurlbaum M, Deutschbein T, Gräsl B, Fassnacht M, Kroiss M.
    Clin Chem; 2021 Jul 06; 67(7):998-1007. PubMed ID: 33997885
    [Abstract] [Full Text] [Related]

  • 16. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Leão ATT, Vieira Neto L.
    J Endocrinol Invest; 2021 Nov 06; 44(11):2455-2463. PubMed ID: 33788166
    [Abstract] [Full Text] [Related]

  • 17. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P, Orsolini F, Benelli E, Agretti P, Vitti P, Di Cosmo C, Tonacchera M.
    Endocrine; 2021 Jan 06; 71(1):178-188. PubMed ID: 32915435
    [Abstract] [Full Text] [Related]

  • 18. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.
    J Endocrinol Invest; 2011 Jan 06; 34(1):e1-5. PubMed ID: 20634637
    [Abstract] [Full Text] [Related]

  • 19. Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome.
    Bäcklund N, Brattsand G, Israelsson M, Ragnarsson O, Burman P, Edén Engström B, Høybye C, Berinder K, Wahlberg J, Olsson T, Dahlqvist P.
    Eur J Endocrinol; 2020 Jun 06; 182(6):569-582. PubMed ID: 32213657
    [Abstract] [Full Text] [Related]

  • 20. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M.
    Endocrine; 2019 Dec 06; 66(3):650-659. PubMed ID: 31473918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.